Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DX5XRK
|
||||
| Drug Name |
2-(1-(3-(7-propyl-3-(trifluoromethyl)benzo[d]isoxazol-6-yloxy)propyl)-1H-indazol-5-yl)acetic acid
|
||||
| Synonyms |
CHEMBL210917
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C23H22F3N3O4
|
||||
| Canonical SMILES |
CCCc1c(OCCCn2ncc3cc(CC(=O)O)ccc23)ccc4c(noc14)C(F)(F)F
|
||||
| InChI |
InChI=1S/C23H22F3N3O4/c1-2-4-16-19(8-6-17-21(16)33-28-22(17)23(24,25)26)32-10-3-9-29-18-7-5-14(12-20(30)31)11-15(18)13-27-29/h5-8,11,13H,2-4,9-10,12H2,1H3,(H,30,31)
|
||||
| InChIKey |
ZFCIXIWMXLHUDY-UHFFFAOYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Peroxisomeproliferator activated receptor delta | Target Info | [1587926] | ||
| Oxysterols receptor LXR-alpha | Target Info | [1587926] | |||
| NetPath Pathway | IL2 Signaling Pathway | ||||
| PANTHER Pathway | Wnt signaling pathway | ||||
| WikiPathways | Wnt Signaling Pathway and Pluripotency | ||||
| Nuclear Receptors in Lipid Metabolism and Toxicity | |||||
| NRF2 pathway | |||||
| Nuclear Receptors Meta-Pathway | |||||
| Vitamin D Receptor Pathway | |||||
| Ectoderm Differentiation | |||||
| Adipogenesis | |||||
| Nuclear ReceptorsWP299:Nuclear Receptors in Lipid Metabolism and Toxicity | |||||
| PPAR Alpha Pathway | |||||
| Liver X Receptor Pathway | |||||
| SREBF and miR33 in cholesterol and lipid homeostasis | |||||
| Nuclear Receptors | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.